Hospital Medicine

Diffuse Parenchymal Lung Disease

Questions discussed in this category

How do you approach the use of benzodiazepines in patients with chronic medical illnesses that may be susceptible to respiratory compromise (e.g., CHF, COPD, ILD)?

Should you work to wean patients of benzodiazepines? Is your approach different for patients who have been on benzodiazepines for years? What would yo...

5 Answers available

What are the next steps in the management of a patient admitted with an IPF exacerbation resistant to steroid therapy?

2 Answers available

Papers discussed in this category

The Lancet. Respiratory medicine, 2021 Sep 07

Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial.

American journal of respiratory and critical care medicine, 2020 May 01

Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Randomized, Double-Blind Placebo-controlled Trial.

Chest, 2018 Jun 30

Effect of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplantation Outcome.

The European respiratory journal, 2010 Jul 01

Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome.

Transplantation, 2024 May 23

Impact of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplant Outcomes.

Hospital Medicine

Diffuse Parenchymal Lung Disease

Questions discussed in this category

Papers discussed in this category

Related Topics in Hospital Medicine